These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 31754133)
21. Race-Specific Comparisons of Antihypertensive and Metabolic Effects of Hydrochlorothiazide and Chlorthalidone. Chekka LMS; Chapman AB; Gums JG; Cooper-DeHoff RM; Johnson JA Am J Med; 2021 Jul; 134(7):918-925.e2. PubMed ID: 33434556 [TBL] [Abstract][Full Text] [Related]
22. Hydrochlorothiazide is not the most useful nor versatile thiazide diuretic. Vongpatanasin W Curr Opin Cardiol; 2015 Jul; 30(4):361-5. PubMed ID: 26049382 [TBL] [Abstract][Full Text] [Related]
23. Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers. Cunningham PN; Wang Z; Grove ML; Cooper-DeHoff RM; Beitelshees AL; Gong Y; Gums JG; Johnson JA; Turner ST; Boerwinkle E; Chapman AB PLoS One; 2019; 14(9):e0221957. PubMed ID: 31532792 [TBL] [Abstract][Full Text] [Related]
24. The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study. Do AN; Lynch AI; Claas SA; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Tiwari HK; Arnett DK; Irvin MR J Hum Hypertens; 2016 Sep; 30(9):549-54. PubMed ID: 26791477 [TBL] [Abstract][Full Text] [Related]
25. Comparison of Blood Pressure Control Rates Among Recommended Drug Selection Strategies for Initial Therapy of Hypertension. Gharaibeh KA; Turner ST; Hamadah AM; Chapman AB; Cooper-Dehoff RM; Johnson JA; Gums JG; Bailey KR; Schwartz GL Am J Hypertens; 2016 Oct; 29(10):1186-94. PubMed ID: 27365079 [TBL] [Abstract][Full Text] [Related]
26. PTPRD gene associated with blood pressure response to atenolol and resistant hypertension. Gong Y; McDonough CW; Beitelshees AL; El Rouby N; Hiltunen TP; O'Connell JR; Padmanabhan S; Langaee TY; Hall K; Schmidt SO; Curry RW; Gums JG; Donner KM; Kontula KK; Bailey KR; Boerwinkle E; Takahashi A; Tanaka T; Kubo M; Chapman AB; Turner ST; Pepine CJ; Cooper-DeHoff RM; Johnson JA J Hypertens; 2015 Nov; 33(11):2278-85. PubMed ID: 26425837 [TBL] [Abstract][Full Text] [Related]
27. Chlorthalidone versus hydrochlorothiazide for preventing cardiovascular disease in hypertension: Is the case closed? Kollias A; Kyriakoulis KG; Stergiou GS Hellenic J Cardiol; 2023; 73():84-85. PubMed ID: 37429505 [TBL] [Abstract][Full Text] [Related]
28. Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression. Duarte JD; Turner ST; Tran B; Chapman AB; Bailey KR; Gong Y; Gums JG; Langaee TY; Beitelshees AL; Cooper-Dehoff RM; Boerwinkle E; Johnson JA Pharmacogenomics J; 2013 Jun; 13(3):257-63. PubMed ID: 22350108 [TBL] [Abstract][Full Text] [Related]
29. Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study. Gong Y; McDonough CW; Wang Z; Hou W; Cooper-DeHoff RM; Langaee TY; Beitelshees AL; Chapman AB; Gums JG; Bailey KR; Boerwinkle E; Turner ST; Johnson JA Circ Cardiovasc Genet; 2012 Dec; 5(6):686-91. PubMed ID: 23087401 [TBL] [Abstract][Full Text] [Related]
30. Alteration in fasting glucose after prolonged treatment with a thiazide diuretic. Karnes JH; Gong Y; Arwood MJ; Gums JG; Hall KL; Limacher MC; Johnson JA; Cooper-DeHoff RM Diabetes Res Clin Pract; 2014 Jun; 104(3):363-9. PubMed ID: 24794890 [TBL] [Abstract][Full Text] [Related]
31. Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics. McDonough CW; Burbage SE; Duarte JD; Gong Y; Langaee TY; Turner ST; Gums JG; Chapman AB; Bailey KR; Beitelshees AL; Boerwinkle E; Pepine CJ; Cooper-DeHoff RM; Johnson JA J Hypertens; 2013 Apr; 31(4):698-704. PubMed ID: 23353631 [TBL] [Abstract][Full Text] [Related]
32. Evidence-based diuretics: focus on chlorthalidone and indapamide. DiNicolantonio JJ; Bhutani J; Lavie CJ; O'Keefe JH Future Cardiol; 2015 Mar; 11(2):203-17. PubMed ID: 25760879 [TBL] [Abstract][Full Text] [Related]
33. A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration. Shahin MH; Gong Y; McDonough CW; Rotroff DM; Beitelshees AL; Garrett TJ; Gums JG; Motsinger-Reif A; Chapman AB; Turner ST; Boerwinkle E; Frye RF; Fiehn O; Cooper-DeHoff RM; Kaddurah-Daouk R; Johnson JA Hypertension; 2016 Sep; 68(3):621-9. PubMed ID: 27381900 [TBL] [Abstract][Full Text] [Related]
34. Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Fox ER; Young JH; Li Y; Dreisbach AW; Keating BJ; Musani SK; Liu K; Morrison AC; Ganesh S; Kutlar A; Ramachandran VS; Polak JF; Fabsitz RR; Dries DL; Farlow DN; Redline S; Adeyemo A; Hirschorn JN; Sun YV; Wyatt SB; Penman AD; Palmas W; Rotter JI; Townsend RR; Doumatey AP; Tayo BO; Mosley TH; Lyon HN; Kang SJ; Rotimi CN; Cooper RS; Franceschini N; Curb JD; Martin LW; Eaton CB; Kardia SL; Taylor HA; Caulfield MJ; Ehret GB; Johnson T; ; Chakravarti A; Zhu X; Levy D Hum Mol Genet; 2011 Jun; 20(11):2273-84. PubMed ID: 21378095 [TBL] [Abstract][Full Text] [Related]
35. Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestry. de las Fuentes L; Sung YJ; Sitlani CM; Avery CL; Bartz TM; Keyser C; Evans DS; Li X; Musani SK; Ruiter R; Smith AV; Sun F; Trompet S; Xu H; Arnett DK; Bis JC; Broeckel U; Busch EL; Chen YI; Correa A; Cummings SR; Floyd JS; Ford I; Guo X; Harris TB; Ikram MA; Lange L; Launer LJ; Reiner AP; Schwander K; Smith NL; Sotoodehnia N; Stewart JD; Stott DJ; Stürmer T; Taylor KD; Uitterlinden A; Vasan RS; Wiggins KL; Cupples LA; Gudnason V; Heckbert SR; Jukema JW; Liu Y; Psaty BM; Rao DC; Rotter JI; Stricker B; Wilson JG; Whitsel EA Pharmacogenomics J; 2020 Jun; 20(3):482-493. PubMed ID: 31806883 [TBL] [Abstract][Full Text] [Related]
36. Hydrochlorothiazide versus chlorthalidone in the management of hypertension. Neff KM; Nawarskas JJ Cardiol Rev; 2010; 18(1):51-6. PubMed ID: 20010338 [TBL] [Abstract][Full Text] [Related]
37. Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension. Cushman WC; Bakris GL; White WB; Weber MA; Sica D; Roberts A; Lloyd E; Kupfer S Hypertension; 2012 Aug; 60(2):310-8. PubMed ID: 22710649 [TBL] [Abstract][Full Text] [Related]
38. Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide. Moore MJ; Gong Y; Hou W; Hall K; Schmidt SO; Curry RW; Beitelshees AL; Chapman A; Turner ST; Schwartz GL; Bailey K; Boerwinkle E; Gums JG; Cooper-DeHoff RM; Johnson JA Pharmacotherapy; 2014 Nov; 34(11):1132-40. PubMed ID: 25202885 [TBL] [Abstract][Full Text] [Related]
39. Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients. Mehanna M; McDonough CW; Smith SM; Gong Y; Gums JG; Chapman AB; Johnson JA; McIntyre L; Cooper-DeHoff RM Metabolites; 2021 Sep; 11(9):. PubMed ID: 34564461 [TBL] [Abstract][Full Text] [Related]
40. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial. Ernst ME; Neaton JD; Grimm RH; Collins G; Thomas W; Soliman EZ; Prineas RJ; Hypertension; 2011 Dec; 58(6):1001-7. PubMed ID: 22025372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]